Biomaterials Market by Type [Metallic (Gold, Magnesium), Ceramic (Aluminum Oxide, Carbon), Polymer (Polyethylene, Polyester), Natural (Hyaluronic acid, Collagen, Gelatin)], Application (Orthopedic, Dental, CVD, Ophthalmology) - Global Forecast to 2030
The global Biomaterials market is projected to reach USD 68.93 billion by 2030 from USD 48.36 billion in 2025, at CAGR of 7.3% from 2025 to 2030. The expansion of the Global Biomaterials market has been fueled by the advancements in healthcare facilities and systems, and the rising advancements in smart, biocompatible, and 3D-printed biomaterials.
“In 2024, The metallic biomaterials held the highest share in the Global Biomaterials market by type.”
The market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, Natural Biomaterials. The highest share by type was of metallic biomaterials due to their wide application in orthopedic, dental, and cardiovascular fields. The mechanical properties make them the suitable for application in implants such as joint replacements, fracture fixation devices, dental implants, and stints. The commonly used biomaterials are titanium and its alloys, stainless steel, cobalt chromoly alloys, and more recently, biodegradable metal alloys like magnesium-based metal. These exhibit remarkable resistance to fatigue failure, corrosion, and remarkable compatibility. They were also found to be safe for long-term use in a physiological environment. However, constant progress in surface modification technologies such as surface modification through coating and surface treatment has greatly improved their osseointegration, friction, and resistance to infections. Moreover, rising surgical procedures, an ageing population, and an increase in musculoskeletal and cardiac disorders are expected to propel the demand for metallic biomaterials across the globe, consolidating their strong position in the global biomaterials.
“Joint replacement segment reported for the highest share of the orthopedic application segment in 2024.”
Within the application segment, the Global Biomaterials market is divided into Cardiovascular, Orthopedic, Ophthalmology, Dental, Plastic Surgery, Tissue engineering, neurological application Wound Healing, Urinary application, and Other Applications. In 2024, Joint replacement represents the leading segment in orthopedic applications in the global biomaterials. Due to an increasing number of people suffering from degenerative joint diseases like osteoarthritis and rheumatoid arthritis. factors like an aging population, and an increasing rate of obesity have also led to an increasing number of people undergoing knee, shoulder, or hip replacements. However, materials used in joint replacements, have improved strength, durability, or biocompatibility that makes these materials highly suitable for applications involving heavy loading. Advances in implant design, surface technology, or method of implantation also continue to increase patient survival with these implants. Furthermore, increasing utilization of minimal invasiveness in surgeries, increasing availability of orthopedic care in developing nations, or ever-improving implant technologies continue to drive this market.
APAC accounted for the fastest growing market share in the global Biomaterials market from 2025 to 2030.
The biomaterials market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. APAC region is projected to grow at the highest CAGR during the forecast period . This surge is driven by rapid healthcare infrastructure expansion in China, India, and Japan, alongside booming medical tourism and rising chronic disease burdens like orthopedics and cardiology. An aging population, government R&D investments, and adoption of 3D-printed implants and bioresorbable polymers fuel demand for advanced metallic, polymeric, and ceramic solutions in joint replacements, stents, and tissue engineering. Local manufacturing hubs and regulatory streamlining further accelerate market penetration, positioning APAC as a key innovation powerhouse.
The primary interviews conducted for this report can be categorized as follows:
Key players in the Global Biomaterials market include BASF SE (Germany), Covestro AG (Germany), Celanese Corporation (US), Carpenter Technology Corporation (US), DSM (Netherlands), Corbion NV (Netherlands), Evonik Industries AG (Germany), Victrex Plc (UK), CeramTec GmbH (Germany), Mitsubishi Chemical Group Corporation (Japan), CoorsTek Inc. (US), Berkeley Advanced Biomaterials (US), CAM Bioceramics B.V. (Netherlands), Zeus Company Inc. (US), AMETEK Inc. (US), and GELITA AG (Germany).
Research Coverage:
This research report categorizes the Global Biomaterials market, By Type: Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, Natural Biomaterials, By Application: Cardiovascular Orthopaedic, Dental, Plastic Surgery, Urinary, Wound Healing, Tissue Engineering, Ophthalmology, Neurological/Central Nervous System, Other Applications. and by region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).
The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the Biomaterials market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New approvals/launches, collaborations, acquisitions, and recent developments associated with the Global Biomaterials market.
Key Benefits of Buying the Report:
The report will help market leaders and new entrants by providing them with the closest approximations of the revenue numbers for the overall Biomaterials market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their businesses and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
“In 2024, The metallic biomaterials held the highest share in the Global Biomaterials market by type.”
The market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, Natural Biomaterials. The highest share by type was of metallic biomaterials due to their wide application in orthopedic, dental, and cardiovascular fields. The mechanical properties make them the suitable for application in implants such as joint replacements, fracture fixation devices, dental implants, and stints. The commonly used biomaterials are titanium and its alloys, stainless steel, cobalt chromoly alloys, and more recently, biodegradable metal alloys like magnesium-based metal. These exhibit remarkable resistance to fatigue failure, corrosion, and remarkable compatibility. They were also found to be safe for long-term use in a physiological environment. However, constant progress in surface modification technologies such as surface modification through coating and surface treatment has greatly improved their osseointegration, friction, and resistance to infections. Moreover, rising surgical procedures, an ageing population, and an increase in musculoskeletal and cardiac disorders are expected to propel the demand for metallic biomaterials across the globe, consolidating their strong position in the global biomaterials.
“Joint replacement segment reported for the highest share of the orthopedic application segment in 2024.”
Within the application segment, the Global Biomaterials market is divided into Cardiovascular, Orthopedic, Ophthalmology, Dental, Plastic Surgery, Tissue engineering, neurological application Wound Healing, Urinary application, and Other Applications. In 2024, Joint replacement represents the leading segment in orthopedic applications in the global biomaterials. Due to an increasing number of people suffering from degenerative joint diseases like osteoarthritis and rheumatoid arthritis. factors like an aging population, and an increasing rate of obesity have also led to an increasing number of people undergoing knee, shoulder, or hip replacements. However, materials used in joint replacements, have improved strength, durability, or biocompatibility that makes these materials highly suitable for applications involving heavy loading. Advances in implant design, surface technology, or method of implantation also continue to increase patient survival with these implants. Furthermore, increasing utilization of minimal invasiveness in surgeries, increasing availability of orthopedic care in developing nations, or ever-improving implant technologies continue to drive this market.
APAC accounted for the fastest growing market share in the global Biomaterials market from 2025 to 2030.
The biomaterials market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. APAC region is projected to grow at the highest CAGR during the forecast period . This surge is driven by rapid healthcare infrastructure expansion in China, India, and Japan, alongside booming medical tourism and rising chronic disease burdens like orthopedics and cardiology. An aging population, government R&D investments, and adoption of 3D-printed implants and bioresorbable polymers fuel demand for advanced metallic, polymeric, and ceramic solutions in joint replacements, stents, and tissue engineering. Local manufacturing hubs and regulatory streamlining further accelerate market penetration, positioning APAC as a key innovation powerhouse.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side-70% and Demand Side-30%
- By Designation: Managers-45%, CXO and Directors-30%, and Executives-25%
- By Region: North America-40%, Europe-25%, the Asia Pacific-25%, Latin America-5%, and the Middle East & Africa-5%
Key players in the Global Biomaterials market include BASF SE (Germany), Covestro AG (Germany), Celanese Corporation (US), Carpenter Technology Corporation (US), DSM (Netherlands), Corbion NV (Netherlands), Evonik Industries AG (Germany), Victrex Plc (UK), CeramTec GmbH (Germany), Mitsubishi Chemical Group Corporation (Japan), CoorsTek Inc. (US), Berkeley Advanced Biomaterials (US), CAM Bioceramics B.V. (Netherlands), Zeus Company Inc. (US), AMETEK Inc. (US), and GELITA AG (Germany).
Research Coverage:
This research report categorizes the Global Biomaterials market, By Type: Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, Natural Biomaterials, By Application: Cardiovascular Orthopaedic, Dental, Plastic Surgery, Urinary, Wound Healing, Tissue Engineering, Ophthalmology, Neurological/Central Nervous System, Other Applications. and by region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).
The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the Biomaterials market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New approvals/launches, collaborations, acquisitions, and recent developments associated with the Global Biomaterials market.
Key Benefits of Buying the Report:
The report will help market leaders and new entrants by providing them with the closest approximations of the revenue numbers for the overall Biomaterials market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their businesses and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (Rising advancements in smart, biocompatible, and 3D-printed biomaterials, Advancements in healthcare facilities and systems), restraints (High development and production costs associated with advanced biomaterials.), opportunities (Expanding applications in tissue engineering and regenerative medicine.) and Challenges (Concerns related to biocompatibility, safety, and adverse immune responses).
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities in the Global Biomaterials market
- Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
- Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the Global Biomaterials market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players. A detailed analysis of the key industry players has been done to provide insights into their key strategies, product launches/ approvals, pipeline analysis, acquisitions, partnerships, agreements, collaborations, other recent developments, investment and funding activities, brand/product comparative analysis, and vendor valuation and financial metrics of the Global Biomaterials market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION
1.3.2 REGIONAL SCOPE
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 RESEARCH LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
2.1 KEY INSIGHTS & MARKET HIGHLIGHTS
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS & STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS SHAPING BIOMATERIALS MARKET
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
3.1 BIOMATERIALS MARKET OVERVIEW
3.2 NORTH AMERICA: BIOMATERIALS MARKET, BY TYPE AND COUNTRY, 2025
3.3 BIOMATERIALS MARKET: GEOGRAPHIC SNAPSHOT
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Rising advancements in smart, biocompatible, and 3D printed biomaterials
4.2.1.2 Advancements in healthcare systems, physical infrastructure, and reimbursement frameworks
4.2.1.3 Growing demand for biomaterials in wound healing and plastic surgery
4.2.1.4 Increasing use of biomaterials in multiple therapeutic areas
4.2.2 RESTRAINTS
4.2.2.1 High development and production cost of advanced biomaterials
4.2.3 OPPORTUNITIES
4.2.3.1 Expanding applications in tissue engineering and regenerative medicine
4.2.3.2 Development of novel biomaterials
4.2.4 CHALLENGES
4.2.4.1 Concerns related to biocompatibility, safety, and adverse immune responses
4.3 UNMET NEEDS & WHITE SPACES
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5 INDUSTRY TRENDS
5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 THREAT OF NEW ENTRANTS
5.1.2 THREAT OF SUBSTITUTES
5.1.3 BARGAINING POWER OF BUYERS
5.1.4 BARGAINING POWER OF SUPPLIERS
5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC OUTLOOK
5.2.1 GDP TRENDS AND FORECAST
5.2.2 TRENDS IN GLOBAL BIOMATERIALS MARKET
5.3 VALUE CHAIN ANALYSIS
5.4 ECOSYSTEM ANALYSIS
5.4.1 ROLE IN ECOSYSTEM
5.5 PRICING ANALYSIS
5.5.1 INDICATIVE SELLING PRICE OF BIOMATERIALS, BY KEY PLAYER, 2025
5.5.2 INDICATIVE SELLING PRICE OF BIOMATERIALS, BY REGION, 2025
5.6 TRADE ANALYSIS
5.6.1 IMPORT DATA FOR HS CODE 7221 (STAINLESS STEEL), 2021–2025
5.6.2 EXPORT DATA FOR HS CODE 7221 (STAINLESS STEEL), 2021–2025
5.6.3 IMPORT VOLUME FOR HS 7221 (STAINLESS STEEL), 2021–2025
5.6.4 EXPORT VOLUME FOR HS CODE 7221 (STAINLESS STEEL), 2021–2025
5.6.5 IMPORT DATA FOR HS CODE 284329 (SILVER), 2021–2025
5.6.6 EXPORT DATA FOR HS CODE 284329 (SILVER), 2021–2025
5.6.7 IMPORT VOLUME FOR HS 284329 (SILVER), 2021–2025
5.6.8 EXPORT VOLUME FOR HS CODE 284329 (SILVER), 2021–2025
5.6.9 IMPORT DATA FOR HS CODE 281820 (ALUMINUM OXIDE), 2021–2025
5.6.10 EXPORT DATA FOR HS CODE 281820 (ALUMINUM OXIDE), 2021–2025
5.6.11 IMPORT VOLUME FOR HS CODE 281820 (ALUMINUM OXIDE), 2021–2025
5.6.12 EXPORT VOLUME FOR HS CODE 281820 (ALUMINUM OXIDE), 2021–2025
5.6.13 IMPORT DATA FOR HS CODE 3910 (SILICONE), 2021–2025
5.6.14 EXPORT DATA FOR HS CODE 3910 (SILICONE), 2021–2025
5.6.15 IMPORT VOLUME FOR HS 3910 (SILICONE), 2021–2025
5.6.16 EXPORT VOLUME FOR HS CODE 3910 (SILICONE), 2021–2025
5.7 KEY CONFERENCES & EVENTS, 2026–2027
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.9 INVESTMENT & FUNDING SCENARIO
5.10 CASE STUDY ANALYSIS
5.10.1 SCALING MEDICAL-GRADE POLYMER SUPPLY THROUGH INTEGRATED VERBUND MANUFACTURING
5.10.2 STRENGTHENING HIGH-PERFORMANCE POLYMER PLATFORMS FOR REGULATED BIOMATERIALS APPLICATIONS
5.10.3 ADVANCING BIORESORBABLE AND BIOCOMPATIBLE MATERIALS FOR CLINICAL AND COMMERCIAL SCALE-UP
5.11 IMPACT OF 2025 US TARIFF ON BIOMATERIALS MARKET
5.11.1 INTRODUCTION
5.11.2 KEY TARIFF RATES
5.11.3 PRICE IMPACT ANALYSIS
5.11.4 IMPACT ON COUNTRY/REGION
5.11.4.1 North America
5.11.4.2 Europe
5.11.4.3 Asia Pacific
5.11.5 IMPACT ON END-USE INDUSTRIES
5.11.5.1 Medical device manufacturers
5.11.5.2 Pharmaceutical & biotechnology companies
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1 TECHNOLOGY ANALYSIS
6.1.1 KEY TECHNOLOGIES
6.1.1.1 Precision technologies
6.1.1.2 Biomimetics
6.1.2 ADJACENT TECHNOLOGIES
6.1.2.1 3D bioprinting
6.1.2.2 Electrospinning
6.2 TECHNOLOGY/PRODUCT ROADMAP
6.3 PATENT ANALYSIS
6.3.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR BIOMATERIAL PATENTS, 2015–2025
6.3.2 LIST OF PATENTS
6.4 FUTURE APPLICATIONS
6.5 IMPACT OF AI/GEN AI ON BIOMATERIALS MARKET
6.5.1 TOP USE CASES AND MARKET POTENTIAL
6.5.2 CASE STUDIES OF AI IMPLEMENTATION
6.5.3 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.5.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI
7 SUSTAINABILITY AND REGULATORY LANDSCAPE
7.1 REGIONAL REGULATIONS & COMPLIANCE
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.2 REGULATORY FRAMEWORK
7.1.3 INDUSTRY STANDARDS
7.2 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
7.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1 DECISION-MAKING PROCESS
8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2 KEY BUYING CRITERIA, BY END USER
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4 UNMET NEEDS FROM KEY END-USE INDUSTRIES
8.5 MARKET PROFITABILITY
9 BIOMATERIALS MARKET, BY TYPE
9.1 INTRODUCTION
9.2 METALLIC BIOMATERIALS
9.2.1 STAINLESS STEEL
9.2.1.1 Favorable mechanical properties, corrosion resistance, and cost-effectiveness to drive usage
9.2.2 TITANIUM & TITANIUM ALLOYS
9.2.2.1 Rising number of joint replacement procedures to aid market growth
9.2.3 COBALT-CHROME ALLOYS
9.2.3.1 Low cost and excellent corrosion resistance to augment market growth
9.2.4 SILVER
9.2.4.1 Toxic properties and low aesthetic to limit use of silver in biomaterial-based products
9.2.5 GOLD
9.2.5.1 Expanding applications of gold nanoparticles to drive demand for gold biomaterials
9.2.6 MAGNESIUM
9.2.6.1 Biodegradable characteristics of magnesium to aid segment growth
9.2.7 OTHER METALLIC BIOMATERIALS
9.3 POLYMERIC BIOMATERIALS
9.3.1 POLYMETHYLMETHACRYLATE (PMMA)
9.3.1.1 Long-standing clinical record demonstrating safety and biocompatibility to spur market growth
9.3.2 POLYETHYLENE
9.3.2.1 Wear and tear resistance of polyethylene to popularize usage in hip and knee joint replacements
9.3.3 POLYESTER
9.3.3.1 Biodegradable nature and biocompatibility to boost use in various medical applications
9.3.4 POLYVINYLCHLORIDE
9.3.4.1 Heavy chlorine content of polyvinylchloride to hamper market growth
9.3.5 SILICONE RUBBER
9.3.5.1 Non-reactive, stable, and resistant in extreme environments and temperatures to drive adoption of silicone rubber
9.3.6 NYLON
9.3.6.1 Low weight, corrosion resistance, and wide applications to propel market demand
9.3.7 POLYETHERETHERKETONE
9.3.7.1 Polyetheretherketone to gain popularity as viable alternative to metals
9.3.8 OTHER POLYMERIC BIOMATERIALS
9.4 CERAMIC BIOMATERIALS
9.4.1 CALCIUM PHOSPHATE
9.4.1.1 Close structural and chemical resemblance to natural bone and teeth to drive adoption in biomedical applications
9.4.2 ZIRCONIA
9.4.2.1 Bio-inertness and low wear rate of zirconia to boost market adoption
9.4.3 ALUMINUM OXIDE
9.4.3.1 Increasing use of aluminum oxide in hip replacements and dental implants to drive market
9.4.4 CALCIUM SULFATE
9.4.4.1 Better biocompatibility and bioresorbability to augment market adoption
9.4.5 CARBON
9.4.5.1 Increasing use of carbon nanofibers in regenerative medicine and cancer treatment to drive market growth
9.4.6 GLASS
9.4.6.1 Rising number of orthopedic and dental procedures to fuel demand for glass biomaterials
9.5 NATURAL BIOMATERIALS
9.5.1 HYALURONIC ACID
9.5.1.1 Rising incidences of osteoarthritis to drive hyaluronic acid biomaterials market
9.5.2 COLLAGEN
9.5.2.1 High tensile strength to be useful in plastic and cosmetic surgeries, cardiology, ophthalmology, and drug delivery
9.5.3 FIBRIN
9.5.3.1 Fibrin biomaterials to be useful in clinical practice for controlling bleeding and accelerating wound repair
9.5.4 CELLULOSE
9.5.4.1 Cellulose to be useful in wound healing, skin regeneration, and ophthalmology
9.5.5 CHITIN
9.5.5.1 Chitin to accelerate skin regeneration and possess high biocompatibility
9.5.6 ALGINATES
9.5.6.1 Use in wound healing, tissue engineering & regenerative medicine, and drug delivery to drive adoption
9.5.7 GELATIN
9.5.7.1 Low cost and comparable biocompatibility of gelatin to fuel market adoption
9.5.8 CHITOSAN
9.5.8.1 Non-toxicity of Chitosan to increase adoption in biomedical research
9.5.9 SILK
9.5.9.1 Flexibility and adhesive abilities to drive usage in wound healing applications
9.5.10 OTHER NATURAL BIOMATERIALS
10 BIOMATERIALS MARKET, BY APPLICATION
10.1 INTRODUCTION
10.2 ORTHOPEDIC
10.2.1 JOINT REPLACEMENT
10.2.1.1 Knee replacement
10.2.1.1.1 Rising count of knee replacement procedures globally to drive market growth
10.2.1.2 Hip replacement
10.2.1.2.1 Hip & knee joint replacements to be most commonly performed procedures
10.2.1.3 Shoulder replacement
10.2.1.3.1 Increasing shoulder surgeries to drive production of implants
10.2.1.4 Other joint replacement applications
10.2.2 BIORESORBABLE TISSUE FIXATION
10.2.2.1 Suture anchors
10.2.2.1.1 Growing awareness about suture anchor devices to propel market growth
10.2.2.2 Interference screws
10.2.2.2.1 Growing ACL reconstruction procedures to contribute to market growth
10.2.2.3 Meniscal repair tacks
10.2.2.3.1 Rising sports injuries to fuel growth in meniscal repair tacks market
10.2.2.4 Meshes
10.2.2.4.1 Wear resistance and proper shaping of bioresorbable implants to increase demand for bioresorbable meshes
10.2.3 SPINE SURGERIES
10.2.3.1 Spinal fusion
10.2.3.1.1 Introduction of minimally invasive spinal fusion procedures and better clinical outcomes to drive market growth
10.2.3.2 Minimally invasive fusion
10.2.3.2.1 Lesser post-surgery pain and faster recovery to drive demand for minimally invasive fusion procedures
10.2.3.3 Motion preservation & dynamic stabilization
10.2.3.3.1 Pedicle-based rod systems
10.2.3.3.1.1 Rising geriatric population to result in market growth
10.2.3.3.2 Interspinous spacers
10.2.3.3.2.1 High prevalence of degenerative spinal conditions to contribute to market growth
10.2.3.3.3 Artificial discs
10.2.3.3.3.1 High biocompatibility to increase usage in artificial discs
10.2.4 FRACTURE FIXATION DEVICES
10.2.4.1 Bone plates
10.2.4.1.1 High biocompatibility of biomaterials to be an integral component of bone plates
10.2.4.2 Screws
10.2.4.2.1 Metallic biomaterial screws to be extensively used in orthopedic procedures
10.2.4.3 Pins
10.2.4.3.1 Nonreactive nature of metallic biomaterial pins to favor usage in fracture fixation
10.2.4.4 Rods
10.2.4.4.1 High rigidity, easy mobility, and cost efficiency to make rods preferred for fracture fixation procedures
10.2.4.5 Wires
10.2.4.5.1 Wires made up of metallic biomaterials to help treat fractures of small bones
10.2.5 ORTHOBIOLOGICS
10.2.5.1 Rising cases of osteoarthritis to drive growth in viscosupplementation market
10.3 CARDIOVASCULAR
10.3.1 CATHETERS
10.3.1.1 Shift in patient preference from traditional open surgeries to minimally invasive surgeries to drive market
10.3.2 STENTS
10.3.2.1 Increasing number of coronary intervention procedures to boost demand for implantable stents
10.3.3 IMPLANTABLE CARDIAC DEFIBRILLATORS
10.3.3.1 Growing geriatric population and rising prevalence of chronic diseases to drive market
10.3.4 PACEMAKERS
10.3.4.1 High prevalence of bradycardia to aid demand for pacemakers
10.3.5 SENSORS
10.3.5.1 Increasing prevalence of cardiac disorders to boost demand for cardiovascular sensors
10.3.6 HEART VALVES
10.3.6.1 Growing geriatric population to increase demand for prosthetic valves
10.3.7 VASCULAR GRAFTS
10.3.7.1 Focus on research on use of biomaterials in vascular grafts to open opportunities for market growth
10.3.8 GUIDEWIRES
10.3.8.1 Guidewires to be used for guiding catheters and placing stents inside the heart
10.3.9 OTHER CARDIOVASCULAR APPLICATIONS
10.4 OPHTHALMOLOGY
10.4.1 CONTACT LENSES
10.4.1.1 Growing cases of refractive errors and preference for contact lenses over spectacles to drive market growth
10.4.2 INTRAOCULAR LENSES
10.4.2.1 Increasing prevalence of cataracts to boost number of cataract surgeries performed
10.4.3 FUNCTIONAL REPLACEMENT OF OCULAR TISSUES
10.4.3.1 Increasing funding and research activities for developing bionic eyes to propel segment growth
10.4.4 SYNTHETIC CORNEAS
10.4.4.1 Increasing number of corneal blindness cases globally to boost demand for synthetic collagen biomaterials
10.4.5 OTHER OPHTHALMOLOGY APPLICATIONS
10.5 DENTAL
10.5.1 DENTAL IMPLANTS
10.5.1.1 Rising awareness about dental health and increasing dental procedures to augment market growth
10.5.2 DENTAL BONE GRAFTS & SUBSTITUTES
10.5.2.1 Growing demand for dental implants during cosmetic dentistry to drive market
10.5.3 DENTAL MEMBRANES
10.5.3.1 Dental membranes in oral and periodontal surgery to prevent unwanted infections in oral cavity
10.5.4 TISSUE REGENERATION MATERIALS
10.5.4.1 Increasing prevalence of periodontal disease to augment market growth
10.6 PLASTIC SURGERY
10.6.1 SOFT TISSUE FILLERS
10.6.1.1 Long-lasting capacity and fewer allergic reactions to drive demand for soft-tissue fillers
10.6.2 CRANIOFACIAL SURGERY
10.6.2.1 Increasing incidence of trauma cases and head & neck cancer to augment market growth
10.6.3 FACIAL WRINKLE TREATMENT
10.6.3.1 Increase in demand for non-surgical cosmetic treatments to propel market growth
10.6.4 BIOENGINEERED SKINS
10.6.4.1 Increasing incidence of trauma cases and head & neck cancer to increase number of craniofacial surgeries
10.6.5 PERIPHERAL NERVE REPAIR
10.6.5.1 Increasing incidence of trauma cases to rise in peripheral nerve injuries
10.6.6 ACELLULAR DERMAL MATRICES
10.6.6.1 Ability to provide scaffold for tissue regeneration and reduce risk of immune rejection and adverse reactions to drive segment
10.7 WOUND HEALING
10.7.1 WOUND CLOSURE DEVICES
10.7.1.1 Sutures
10.7.1.1.1 Sutures to be used as advanced biologically active components for better drug delivery
10.7.1.2 Staples
10.7.1.2.1 Ease of placement and ability to shorten closure to augment segment growth
10.7.2 SURGICAL HEMOSTATS
10.7.2.1 Surgical hemostats to control bleeding and reduce frequent blood transfusions during surgical procedures
10.7.3 INTERNAL TISSUE SEALANTS
10.7.3.1 Increasing number of surgeries to drive use of internal tissue sealants
10.7.4 ADHESION BARRIERS
10.7.4.1 Focus on inflammatory healing process to drive adoption of adhesion barriers in surgical procedures
10.7.5 HERNIA MESHES
10.7.5.1 Polymeric biomaterial-based meshes to be used in hernia repair
10.7.6 SKIN SUBSTITUTES
10.7.6.1 Focus on prompting tissue regeneration and replacing damaged skin with functional tissue to aid market growth
10.8 TISSUE ENGINEERING
10.8.1 SCAFFOLDS FOR BIOMATERIALS
10.8.1.1 Rise in organ transplantation procedures to drive market
10.8.2 NANOMATERIALS FOR BIOSENSING
10.8.2.1 Rising research in nanotechnology to augment market growth
10.8.3 TAILORING OF INORGANIC NANOPARTICLES
10.8.3.1 Growing demand for nanotechnological medical products to drive market
10.9 NEUROLOGICAL/CENTRAL NERVOUS SYSTEM
10.9.1 SHUNTING SYSTEMS
10.9.1.1 Rising cases of hydrocephalus to boost market growth
10.9.2 CORTICAL NEURAL PROSTHETICS
10.9.2.1 Increased use of polymer-coated CNPs to treat paralyzed patients
10.9.3 HYDROGEL SCAFFOLDS FOR CNS REPAIR
10.9.3.1 Increasing incidence of spinal cord surgeries to drive demand for hydrogel scaffolds
10.9.4 NEURAL STEM CELL ENCAPSULATION
10.9.4.1 Lack of substitutes for neurotrauma treatment to boost market growth
10.10 URINARY
10.10.1 URINARY CATHETERS
10.10.1.1 Rise in implant-related cases of biofilm-associated infections to hinder market growth
10.10.2 URETHRAL STENTS
10.10.3 OTHER URINARY APPLICATIONS
10.11 OTHER APPLICATIONS
10.11.1 DRUG DELIVERY SYSTEMS
10.11.2 GASTROINTESTINAL APPLICATIONS
10.11.3 BARIATRIC SURGERY
11 BIOMATERIALS MARKET, BY END USER
11.1 INTRODUCTION
11.2 MEDICAL DEVICE MANUFACTURERS
11.2.1 DEMOGRAPHIC SHIFTS, TECHNOLOGICAL INNOVATION, AND EXPANDING CLINICAL APPLICATIONS TO DRIVE MARKET
11.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
11.3.1 INVESTMENT AND INNOVATION MOMENTUM IN PHARMA & BIOTECH TO ACCELERATE GLOBAL BIOMATERIAL ADOPTION
11.4 OTHER END USERS
12 BIOMATERIALS MARKET, BY REGION
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 US
12.2.1.1 Rising incidence of cancer and ongoing research in developing biocompatible materials to drive market
12.2.2 CANADA
12.2.2.1 Growing incidence of cardiovascular diseases to propel market growth
12.3 EUROPE
12.3.1 GERMANY
12.3.1.1 Rising focus on clinical research and increasing number of patent approvals to aid market growth
12.3.2 UK
12.3.2.1 Increasing research activities and rising number of cardiovascular procedures to support market growth
12.3.3 FRANCE
12.3.3.1 Increased healthcare expenditure and structured regulatory framework to augment market growth
12.3.4 ITALY
12.3.4.1 Rising prevalence of neurological and cardiovascular disorders to boost market growth
12.3.5 SPAIN
12.3.5.1 Increased focus on research for biomaterial development to propel market growth
12.3.6 REST OF EUROPE
12.4 ASIA PACIFIC
12.4.1 CHINA
12.4.1.1 Lucrative medical devices industry and large geriatric population to drive market
12.4.2 JAPAN
12.4.2.1 Growing medical devices industry and rising focus on medical research to support market growth
12.4.3 INDIA
12.4.3.1 Large population base and high focus on medical tourism to aid market growth
12.4.4 SOUTH KOREA
12.4.4.1 High demand for healthcare services and advanced treatments to spur market growth
12.4.5 AUSTRALIA
12.4.5.1 Strategic public and sector-wide investments with clinical trial system reform to underpin biomedical research growth
12.4.6 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.5.1 BRAZIL
12.5.1.1 Gradual increase in pharmaceutical R&D to fuel market growth
12.5.2 MEXICO
12.5.2.1 Rising number of cosmetic procedures to boost adoption of biomaterials
12.5.3 ARGENTINA
12.5.3.1 Increased incidence of cardiovascular diseases and favorable government healthcare system to aid market growth
12.5.4 REST OF LATIN AMERICA
12.6 MIDDLE EAST
12.6.1 GCC COUNTRIES
12.6.1.1 Kingdom of Saudi Arabia
12.6.1.1.1 Increasing prevalence of cardiovascular diseases to drive market
12.6.1.2 UAE
12.6.1.2.1 Strategic partnerships and regulatory alignment to drive global biomaterials market growth
12.6.1.3 Rest of GCC countries
12.6.2 REST OF MIDDLE EAST
12.7 AFRICA
12.7.1 EXPANSION IN HEALTHCARE INDUSTRY AND SUPPORTIVE REGULATORY POLICIES TO AID MARKET GROWTH
13 COMPETITIVE LANDSCAPE
13.1 INTRODUCTION
13.2 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS
13.2.1 STRATEGIES ADOPTED BY KEY PLAYERS IN BIOMATERIALS MARKET
13.3 REVENUE ANALYSIS, 2023–2025
13.4 MARKET SHARE ANALYSIS, 2025
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
13.5.5 COMPETITIVE BENCHMARKING: KEY PLAYERS, 2025
13.5.5.1 Company footprint
13.5.5.2 Region footprint
13.5.5.3 Type footprint
13.5.5.4 Application footprint
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES
13.6.1 PROGRESSIVE COMPANIES
13.6.2 RESPONSIVE COMPANIES
13.6.3 DYNAMIC COMPANIES
13.6.4 STARTING BLOCKS
13.6.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES
13.6.5.1 List of key startups/SMEs
13.6.5.2 Competitive benchmarking of key startups/SMEs
13.7 COMPANY VALUATION & FINANCIAL METRICS
13.7.1 FINANCIAL METRICS
13.7.2 COMPANY VALUATION
13.8 BRAND/PRODUCT COMPARATIVE ANALYSIS
13.9 COMPETITIVE SCENARIO
13.9.1 PRODUCT LAUNCHES
13.9.2 DEALS
13.9.3 EXPANSIONS
14 COMPANY PROFILES
14.1 KEY PLAYERS
14.1.1 BASF SE
14.1.1.1 Business overview
14.1.1.2 Products/Services/Solutions offered
14.1.1.3 Recent developments
14.1.1.3.1 Deals
14.1.1.3.2 Other developments
14.1.1.4 MnM view
14.1.1.4.1 Right to win
14.1.1.4.2 Strategic choices
14.1.1.4.3 Weaknesses & competitive threats
14.1.2 COVESTRO AG
14.1.2.1 Business overview
14.1.2.2 Products/Services/Solutions offered
14.1.2.3 Recent developments
14.1.2.3.1 Product launches
14.1.2.3.2 Deals
14.1.2.3.3 Expansions
14.1.2.3.4 Other developments
14.1.2.4 MnM view
14.1.2.4.1 Right to win
14.1.2.4.2 Strategic choices
14.1.2.4.3 Weaknesses & competitive threats
14.1.3 CELANESE CORPORATION
14.1.3.1 Business overview
14.1.3.2 Products/Services/Solutions offered
14.1.3.3 Recent developments
14.1.3.3.1 Deals
14.1.3.4 MnM view
14.1.3.4.1 Right to win
14.1.3.4.2 Strategic choices
14.1.3.4.3 Weaknesses & competitive threats
14.1.4 CARPENTER TECHNOLOGY CORPORATION
14.1.4.1 Business overview
14.1.4.2 Products/Services/Solutions offered
14.1.4.2.1 Other developments
14.1.4.3 MnM view
14.1.4.3.1 Right to win
14.1.4.3.2 Strategic choices
14.1.4.3.3 Weaknesses & competitive threats
14.1.5 EVONIK INDUSTRIES AG
14.1.5.1 Business overview
14.1.5.2 Products/Services/Solutions offered
14.1.5.3 Recent developments
14.1.5.3.1 Product launches
14.1.5.3.2 Deals
14.1.5.4 MnM view
14.1.5.4.1 Right to win
14.1.5.4.2 Strategic choices
14.1.5.4.3 Weaknesses & competitive threats
14.1.6 DSM
14.1.6.1 Business overview
14.1.6.2 Products/Services/Solutions offered
14.1.6.3 Recent developments
14.1.6.3.1 Deals
14.1.6.3.2 Expansions
14.1.7 CORBION NV
14.1.7.1 Business overview
14.1.7.2 Products/Services/Solutions offered
14.1.7.3 Recent developments
14.1.7.3.1 Expansions
14.1.8 VICTREX PLC
14.1.8.1 Business overview
14.1.8.2 Products/Services/Solutions offered
14.1.8.3 Recent developments
14.1.8.3.1 Product launches
14.1.8.3.2 Expansions
14.1.9 MITSUBISHI CHEMICAL CORPORATION
14.1.9.1 Business overview
14.1.9.2 Products/Services/Solutions offered
14.1.10 COORSTEK INC.
14.1.10.1 Business overview
14.1.10.2 Products/Services/Solutions offered
14.1.11 BERKELEY ADVANCED BIOMATERIALS
14.1.11.1 Business overview
14.1.11.2 Products/Services/Solutions offered
14.1.12 CAM BIOCERAMICS B.V.
14.1.12.1 Business overview
14.1.12.2 Products/Services/Solutions offered
14.1.12.3 Recent developments
14.1.12.3.1 Deals
14.1.13 ZEUS COMPANY INC.
14.1.13.1 Business overview
14.1.13.2 Products/Services/Solutions offered
14.1.13.3 Recent developments
14.1.13.3.1 Product launches
14.1.13.3.2 Expansions
14.1.14 AMETEK INC.
14.1.14.1 Business overview
14.1.14.2 Products/Services/Solutions offered
14.1.14.3 Recent developments
14.1.14.3.1 Deals
14.1.14.3.2 Expansions
14.1.15 GELITA AG
14.1.15.1 Business overview
14.1.15.2 Products/Services/Solutions offered
14.1.15.3 Recent developments
14.1.15.3.1 Product launches
14.2 OTHER PLAYERS
14.2.1 COLLAGEN SOLUTIONS (US) LLC)
14.2.2 BIOCOMPOSITES
14.2.3 NOBLE BIOMATERIALS, INC.
14.2.4 REGENITY
14.2.5 KURARAY CO., LTD.
14.2.6 SOLESIS
14.2.7 INSTITUT STRAUMANN AG
14.2.8 FOSTER CORPORATION
14.2.9 CDI PRODUCTS
14.2.10 REVBIO, INC.
15 RESEARCH METHODOLOGY
15.1 RESEARCH DATA
15.1.1 SECONDARY DATA
15.1.1.1 Key objectives of secondary research
15.1.2 PRIMARY DATA
15.1.2.1 Breakdown of primaries
15.1.2.2 Key objectives of primary research
15.2 MARKET ESTIMATION METHODOLOGY
15.3 MARKET SIZE ESTIMATION
15.3.1 COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH)
15.3.2 MNM REPOSITORY ANALYSIS
15.3.3 PRIMARY INTERVIEWS
15.3.4 INSIGHTS OF PRIMARY EXPERTS
15.3.5 TOP-DOWN APPROACH
15.4 MARKET GROWTH RATE PROJECTIONS
15.5 DATA TRIANGULATION
15.6 STUDY ASSUMPTIONS
15.7 RESEARCH LIMITATIONS
15.8 RISK ANALYSIS
16 APPENDIX
16.1 DISCUSSION GUIDE
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3 CUSTOMIZATION OPTIONS
16.4 RELATED REPORTS
16.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION
1.3.2 REGIONAL SCOPE
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 RESEARCH LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
2.1 KEY INSIGHTS & MARKET HIGHLIGHTS
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS & STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS SHAPING BIOMATERIALS MARKET
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
3.1 BIOMATERIALS MARKET OVERVIEW
3.2 NORTH AMERICA: BIOMATERIALS MARKET, BY TYPE AND COUNTRY, 2025
3.3 BIOMATERIALS MARKET: GEOGRAPHIC SNAPSHOT
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Rising advancements in smart, biocompatible, and 3D printed biomaterials
4.2.1.2 Advancements in healthcare systems, physical infrastructure, and reimbursement frameworks
4.2.1.3 Growing demand for biomaterials in wound healing and plastic surgery
4.2.1.4 Increasing use of biomaterials in multiple therapeutic areas
4.2.2 RESTRAINTS
4.2.2.1 High development and production cost of advanced biomaterials
4.2.3 OPPORTUNITIES
4.2.3.1 Expanding applications in tissue engineering and regenerative medicine
4.2.3.2 Development of novel biomaterials
4.2.4 CHALLENGES
4.2.4.1 Concerns related to biocompatibility, safety, and adverse immune responses
4.3 UNMET NEEDS & WHITE SPACES
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5 INDUSTRY TRENDS
5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 THREAT OF NEW ENTRANTS
5.1.2 THREAT OF SUBSTITUTES
5.1.3 BARGAINING POWER OF BUYERS
5.1.4 BARGAINING POWER OF SUPPLIERS
5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC OUTLOOK
5.2.1 GDP TRENDS AND FORECAST
5.2.2 TRENDS IN GLOBAL BIOMATERIALS MARKET
5.3 VALUE CHAIN ANALYSIS
5.4 ECOSYSTEM ANALYSIS
5.4.1 ROLE IN ECOSYSTEM
5.5 PRICING ANALYSIS
5.5.1 INDICATIVE SELLING PRICE OF BIOMATERIALS, BY KEY PLAYER, 2025
5.5.2 INDICATIVE SELLING PRICE OF BIOMATERIALS, BY REGION, 2025
5.6 TRADE ANALYSIS
5.6.1 IMPORT DATA FOR HS CODE 7221 (STAINLESS STEEL), 2021–2025
5.6.2 EXPORT DATA FOR HS CODE 7221 (STAINLESS STEEL), 2021–2025
5.6.3 IMPORT VOLUME FOR HS 7221 (STAINLESS STEEL), 2021–2025
5.6.4 EXPORT VOLUME FOR HS CODE 7221 (STAINLESS STEEL), 2021–2025
5.6.5 IMPORT DATA FOR HS CODE 284329 (SILVER), 2021–2025
5.6.6 EXPORT DATA FOR HS CODE 284329 (SILVER), 2021–2025
5.6.7 IMPORT VOLUME FOR HS 284329 (SILVER), 2021–2025
5.6.8 EXPORT VOLUME FOR HS CODE 284329 (SILVER), 2021–2025
5.6.9 IMPORT DATA FOR HS CODE 281820 (ALUMINUM OXIDE), 2021–2025
5.6.10 EXPORT DATA FOR HS CODE 281820 (ALUMINUM OXIDE), 2021–2025
5.6.11 IMPORT VOLUME FOR HS CODE 281820 (ALUMINUM OXIDE), 2021–2025
5.6.12 EXPORT VOLUME FOR HS CODE 281820 (ALUMINUM OXIDE), 2021–2025
5.6.13 IMPORT DATA FOR HS CODE 3910 (SILICONE), 2021–2025
5.6.14 EXPORT DATA FOR HS CODE 3910 (SILICONE), 2021–2025
5.6.15 IMPORT VOLUME FOR HS 3910 (SILICONE), 2021–2025
5.6.16 EXPORT VOLUME FOR HS CODE 3910 (SILICONE), 2021–2025
5.7 KEY CONFERENCES & EVENTS, 2026–2027
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.9 INVESTMENT & FUNDING SCENARIO
5.10 CASE STUDY ANALYSIS
5.10.1 SCALING MEDICAL-GRADE POLYMER SUPPLY THROUGH INTEGRATED VERBUND MANUFACTURING
5.10.2 STRENGTHENING HIGH-PERFORMANCE POLYMER PLATFORMS FOR REGULATED BIOMATERIALS APPLICATIONS
5.10.3 ADVANCING BIORESORBABLE AND BIOCOMPATIBLE MATERIALS FOR CLINICAL AND COMMERCIAL SCALE-UP
5.11 IMPACT OF 2025 US TARIFF ON BIOMATERIALS MARKET
5.11.1 INTRODUCTION
5.11.2 KEY TARIFF RATES
5.11.3 PRICE IMPACT ANALYSIS
5.11.4 IMPACT ON COUNTRY/REGION
5.11.4.1 North America
5.11.4.2 Europe
5.11.4.3 Asia Pacific
5.11.5 IMPACT ON END-USE INDUSTRIES
5.11.5.1 Medical device manufacturers
5.11.5.2 Pharmaceutical & biotechnology companies
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1 TECHNOLOGY ANALYSIS
6.1.1 KEY TECHNOLOGIES
6.1.1.1 Precision technologies
6.1.1.2 Biomimetics
6.1.2 ADJACENT TECHNOLOGIES
6.1.2.1 3D bioprinting
6.1.2.2 Electrospinning
6.2 TECHNOLOGY/PRODUCT ROADMAP
6.3 PATENT ANALYSIS
6.3.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR BIOMATERIAL PATENTS, 2015–2025
6.3.2 LIST OF PATENTS
6.4 FUTURE APPLICATIONS
6.5 IMPACT OF AI/GEN AI ON BIOMATERIALS MARKET
6.5.1 TOP USE CASES AND MARKET POTENTIAL
6.5.2 CASE STUDIES OF AI IMPLEMENTATION
6.5.3 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.5.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI
7 SUSTAINABILITY AND REGULATORY LANDSCAPE
7.1 REGIONAL REGULATIONS & COMPLIANCE
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.2 REGULATORY FRAMEWORK
7.1.3 INDUSTRY STANDARDS
7.2 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
7.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1 DECISION-MAKING PROCESS
8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2 KEY BUYING CRITERIA, BY END USER
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4 UNMET NEEDS FROM KEY END-USE INDUSTRIES
8.5 MARKET PROFITABILITY
9 BIOMATERIALS MARKET, BY TYPE
9.1 INTRODUCTION
9.2 METALLIC BIOMATERIALS
9.2.1 STAINLESS STEEL
9.2.1.1 Favorable mechanical properties, corrosion resistance, and cost-effectiveness to drive usage
9.2.2 TITANIUM & TITANIUM ALLOYS
9.2.2.1 Rising number of joint replacement procedures to aid market growth
9.2.3 COBALT-CHROME ALLOYS
9.2.3.1 Low cost and excellent corrosion resistance to augment market growth
9.2.4 SILVER
9.2.4.1 Toxic properties and low aesthetic to limit use of silver in biomaterial-based products
9.2.5 GOLD
9.2.5.1 Expanding applications of gold nanoparticles to drive demand for gold biomaterials
9.2.6 MAGNESIUM
9.2.6.1 Biodegradable characteristics of magnesium to aid segment growth
9.2.7 OTHER METALLIC BIOMATERIALS
9.3 POLYMERIC BIOMATERIALS
9.3.1 POLYMETHYLMETHACRYLATE (PMMA)
9.3.1.1 Long-standing clinical record demonstrating safety and biocompatibility to spur market growth
9.3.2 POLYETHYLENE
9.3.2.1 Wear and tear resistance of polyethylene to popularize usage in hip and knee joint replacements
9.3.3 POLYESTER
9.3.3.1 Biodegradable nature and biocompatibility to boost use in various medical applications
9.3.4 POLYVINYLCHLORIDE
9.3.4.1 Heavy chlorine content of polyvinylchloride to hamper market growth
9.3.5 SILICONE RUBBER
9.3.5.1 Non-reactive, stable, and resistant in extreme environments and temperatures to drive adoption of silicone rubber
9.3.6 NYLON
9.3.6.1 Low weight, corrosion resistance, and wide applications to propel market demand
9.3.7 POLYETHERETHERKETONE
9.3.7.1 Polyetheretherketone to gain popularity as viable alternative to metals
9.3.8 OTHER POLYMERIC BIOMATERIALS
9.4 CERAMIC BIOMATERIALS
9.4.1 CALCIUM PHOSPHATE
9.4.1.1 Close structural and chemical resemblance to natural bone and teeth to drive adoption in biomedical applications
9.4.2 ZIRCONIA
9.4.2.1 Bio-inertness and low wear rate of zirconia to boost market adoption
9.4.3 ALUMINUM OXIDE
9.4.3.1 Increasing use of aluminum oxide in hip replacements and dental implants to drive market
9.4.4 CALCIUM SULFATE
9.4.4.1 Better biocompatibility and bioresorbability to augment market adoption
9.4.5 CARBON
9.4.5.1 Increasing use of carbon nanofibers in regenerative medicine and cancer treatment to drive market growth
9.4.6 GLASS
9.4.6.1 Rising number of orthopedic and dental procedures to fuel demand for glass biomaterials
9.5 NATURAL BIOMATERIALS
9.5.1 HYALURONIC ACID
9.5.1.1 Rising incidences of osteoarthritis to drive hyaluronic acid biomaterials market
9.5.2 COLLAGEN
9.5.2.1 High tensile strength to be useful in plastic and cosmetic surgeries, cardiology, ophthalmology, and drug delivery
9.5.3 FIBRIN
9.5.3.1 Fibrin biomaterials to be useful in clinical practice for controlling bleeding and accelerating wound repair
9.5.4 CELLULOSE
9.5.4.1 Cellulose to be useful in wound healing, skin regeneration, and ophthalmology
9.5.5 CHITIN
9.5.5.1 Chitin to accelerate skin regeneration and possess high biocompatibility
9.5.6 ALGINATES
9.5.6.1 Use in wound healing, tissue engineering & regenerative medicine, and drug delivery to drive adoption
9.5.7 GELATIN
9.5.7.1 Low cost and comparable biocompatibility of gelatin to fuel market adoption
9.5.8 CHITOSAN
9.5.8.1 Non-toxicity of Chitosan to increase adoption in biomedical research
9.5.9 SILK
9.5.9.1 Flexibility and adhesive abilities to drive usage in wound healing applications
9.5.10 OTHER NATURAL BIOMATERIALS
10 BIOMATERIALS MARKET, BY APPLICATION
10.1 INTRODUCTION
10.2 ORTHOPEDIC
10.2.1 JOINT REPLACEMENT
10.2.1.1 Knee replacement
10.2.1.1.1 Rising count of knee replacement procedures globally to drive market growth
10.2.1.2 Hip replacement
10.2.1.2.1 Hip & knee joint replacements to be most commonly performed procedures
10.2.1.3 Shoulder replacement
10.2.1.3.1 Increasing shoulder surgeries to drive production of implants
10.2.1.4 Other joint replacement applications
10.2.2 BIORESORBABLE TISSUE FIXATION
10.2.2.1 Suture anchors
10.2.2.1.1 Growing awareness about suture anchor devices to propel market growth
10.2.2.2 Interference screws
10.2.2.2.1 Growing ACL reconstruction procedures to contribute to market growth
10.2.2.3 Meniscal repair tacks
10.2.2.3.1 Rising sports injuries to fuel growth in meniscal repair tacks market
10.2.2.4 Meshes
10.2.2.4.1 Wear resistance and proper shaping of bioresorbable implants to increase demand for bioresorbable meshes
10.2.3 SPINE SURGERIES
10.2.3.1 Spinal fusion
10.2.3.1.1 Introduction of minimally invasive spinal fusion procedures and better clinical outcomes to drive market growth
10.2.3.2 Minimally invasive fusion
10.2.3.2.1 Lesser post-surgery pain and faster recovery to drive demand for minimally invasive fusion procedures
10.2.3.3 Motion preservation & dynamic stabilization
10.2.3.3.1 Pedicle-based rod systems
10.2.3.3.1.1 Rising geriatric population to result in market growth
10.2.3.3.2 Interspinous spacers
10.2.3.3.2.1 High prevalence of degenerative spinal conditions to contribute to market growth
10.2.3.3.3 Artificial discs
10.2.3.3.3.1 High biocompatibility to increase usage in artificial discs
10.2.4 FRACTURE FIXATION DEVICES
10.2.4.1 Bone plates
10.2.4.1.1 High biocompatibility of biomaterials to be an integral component of bone plates
10.2.4.2 Screws
10.2.4.2.1 Metallic biomaterial screws to be extensively used in orthopedic procedures
10.2.4.3 Pins
10.2.4.3.1 Nonreactive nature of metallic biomaterial pins to favor usage in fracture fixation
10.2.4.4 Rods
10.2.4.4.1 High rigidity, easy mobility, and cost efficiency to make rods preferred for fracture fixation procedures
10.2.4.5 Wires
10.2.4.5.1 Wires made up of metallic biomaterials to help treat fractures of small bones
10.2.5 ORTHOBIOLOGICS
10.2.5.1 Rising cases of osteoarthritis to drive growth in viscosupplementation market
10.3 CARDIOVASCULAR
10.3.1 CATHETERS
10.3.1.1 Shift in patient preference from traditional open surgeries to minimally invasive surgeries to drive market
10.3.2 STENTS
10.3.2.1 Increasing number of coronary intervention procedures to boost demand for implantable stents
10.3.3 IMPLANTABLE CARDIAC DEFIBRILLATORS
10.3.3.1 Growing geriatric population and rising prevalence of chronic diseases to drive market
10.3.4 PACEMAKERS
10.3.4.1 High prevalence of bradycardia to aid demand for pacemakers
10.3.5 SENSORS
10.3.5.1 Increasing prevalence of cardiac disorders to boost demand for cardiovascular sensors
10.3.6 HEART VALVES
10.3.6.1 Growing geriatric population to increase demand for prosthetic valves
10.3.7 VASCULAR GRAFTS
10.3.7.1 Focus on research on use of biomaterials in vascular grafts to open opportunities for market growth
10.3.8 GUIDEWIRES
10.3.8.1 Guidewires to be used for guiding catheters and placing stents inside the heart
10.3.9 OTHER CARDIOVASCULAR APPLICATIONS
10.4 OPHTHALMOLOGY
10.4.1 CONTACT LENSES
10.4.1.1 Growing cases of refractive errors and preference for contact lenses over spectacles to drive market growth
10.4.2 INTRAOCULAR LENSES
10.4.2.1 Increasing prevalence of cataracts to boost number of cataract surgeries performed
10.4.3 FUNCTIONAL REPLACEMENT OF OCULAR TISSUES
10.4.3.1 Increasing funding and research activities for developing bionic eyes to propel segment growth
10.4.4 SYNTHETIC CORNEAS
10.4.4.1 Increasing number of corneal blindness cases globally to boost demand for synthetic collagen biomaterials
10.4.5 OTHER OPHTHALMOLOGY APPLICATIONS
10.5 DENTAL
10.5.1 DENTAL IMPLANTS
10.5.1.1 Rising awareness about dental health and increasing dental procedures to augment market growth
10.5.2 DENTAL BONE GRAFTS & SUBSTITUTES
10.5.2.1 Growing demand for dental implants during cosmetic dentistry to drive market
10.5.3 DENTAL MEMBRANES
10.5.3.1 Dental membranes in oral and periodontal surgery to prevent unwanted infections in oral cavity
10.5.4 TISSUE REGENERATION MATERIALS
10.5.4.1 Increasing prevalence of periodontal disease to augment market growth
10.6 PLASTIC SURGERY
10.6.1 SOFT TISSUE FILLERS
10.6.1.1 Long-lasting capacity and fewer allergic reactions to drive demand for soft-tissue fillers
10.6.2 CRANIOFACIAL SURGERY
10.6.2.1 Increasing incidence of trauma cases and head & neck cancer to augment market growth
10.6.3 FACIAL WRINKLE TREATMENT
10.6.3.1 Increase in demand for non-surgical cosmetic treatments to propel market growth
10.6.4 BIOENGINEERED SKINS
10.6.4.1 Increasing incidence of trauma cases and head & neck cancer to increase number of craniofacial surgeries
10.6.5 PERIPHERAL NERVE REPAIR
10.6.5.1 Increasing incidence of trauma cases to rise in peripheral nerve injuries
10.6.6 ACELLULAR DERMAL MATRICES
10.6.6.1 Ability to provide scaffold for tissue regeneration and reduce risk of immune rejection and adverse reactions to drive segment
10.7 WOUND HEALING
10.7.1 WOUND CLOSURE DEVICES
10.7.1.1 Sutures
10.7.1.1.1 Sutures to be used as advanced biologically active components for better drug delivery
10.7.1.2 Staples
10.7.1.2.1 Ease of placement and ability to shorten closure to augment segment growth
10.7.2 SURGICAL HEMOSTATS
10.7.2.1 Surgical hemostats to control bleeding and reduce frequent blood transfusions during surgical procedures
10.7.3 INTERNAL TISSUE SEALANTS
10.7.3.1 Increasing number of surgeries to drive use of internal tissue sealants
10.7.4 ADHESION BARRIERS
10.7.4.1 Focus on inflammatory healing process to drive adoption of adhesion barriers in surgical procedures
10.7.5 HERNIA MESHES
10.7.5.1 Polymeric biomaterial-based meshes to be used in hernia repair
10.7.6 SKIN SUBSTITUTES
10.7.6.1 Focus on prompting tissue regeneration and replacing damaged skin with functional tissue to aid market growth
10.8 TISSUE ENGINEERING
10.8.1 SCAFFOLDS FOR BIOMATERIALS
10.8.1.1 Rise in organ transplantation procedures to drive market
10.8.2 NANOMATERIALS FOR BIOSENSING
10.8.2.1 Rising research in nanotechnology to augment market growth
10.8.3 TAILORING OF INORGANIC NANOPARTICLES
10.8.3.1 Growing demand for nanotechnological medical products to drive market
10.9 NEUROLOGICAL/CENTRAL NERVOUS SYSTEM
10.9.1 SHUNTING SYSTEMS
10.9.1.1 Rising cases of hydrocephalus to boost market growth
10.9.2 CORTICAL NEURAL PROSTHETICS
10.9.2.1 Increased use of polymer-coated CNPs to treat paralyzed patients
10.9.3 HYDROGEL SCAFFOLDS FOR CNS REPAIR
10.9.3.1 Increasing incidence of spinal cord surgeries to drive demand for hydrogel scaffolds
10.9.4 NEURAL STEM CELL ENCAPSULATION
10.9.4.1 Lack of substitutes for neurotrauma treatment to boost market growth
10.10 URINARY
10.10.1 URINARY CATHETERS
10.10.1.1 Rise in implant-related cases of biofilm-associated infections to hinder market growth
10.10.2 URETHRAL STENTS
10.10.3 OTHER URINARY APPLICATIONS
10.11 OTHER APPLICATIONS
10.11.1 DRUG DELIVERY SYSTEMS
10.11.2 GASTROINTESTINAL APPLICATIONS
10.11.3 BARIATRIC SURGERY
11 BIOMATERIALS MARKET, BY END USER
11.1 INTRODUCTION
11.2 MEDICAL DEVICE MANUFACTURERS
11.2.1 DEMOGRAPHIC SHIFTS, TECHNOLOGICAL INNOVATION, AND EXPANDING CLINICAL APPLICATIONS TO DRIVE MARKET
11.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
11.3.1 INVESTMENT AND INNOVATION MOMENTUM IN PHARMA & BIOTECH TO ACCELERATE GLOBAL BIOMATERIAL ADOPTION
11.4 OTHER END USERS
12 BIOMATERIALS MARKET, BY REGION
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 US
12.2.1.1 Rising incidence of cancer and ongoing research in developing biocompatible materials to drive market
12.2.2 CANADA
12.2.2.1 Growing incidence of cardiovascular diseases to propel market growth
12.3 EUROPE
12.3.1 GERMANY
12.3.1.1 Rising focus on clinical research and increasing number of patent approvals to aid market growth
12.3.2 UK
12.3.2.1 Increasing research activities and rising number of cardiovascular procedures to support market growth
12.3.3 FRANCE
12.3.3.1 Increased healthcare expenditure and structured regulatory framework to augment market growth
12.3.4 ITALY
12.3.4.1 Rising prevalence of neurological and cardiovascular disorders to boost market growth
12.3.5 SPAIN
12.3.5.1 Increased focus on research for biomaterial development to propel market growth
12.3.6 REST OF EUROPE
12.4 ASIA PACIFIC
12.4.1 CHINA
12.4.1.1 Lucrative medical devices industry and large geriatric population to drive market
12.4.2 JAPAN
12.4.2.1 Growing medical devices industry and rising focus on medical research to support market growth
12.4.3 INDIA
12.4.3.1 Large population base and high focus on medical tourism to aid market growth
12.4.4 SOUTH KOREA
12.4.4.1 High demand for healthcare services and advanced treatments to spur market growth
12.4.5 AUSTRALIA
12.4.5.1 Strategic public and sector-wide investments with clinical trial system reform to underpin biomedical research growth
12.4.6 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.5.1 BRAZIL
12.5.1.1 Gradual increase in pharmaceutical R&D to fuel market growth
12.5.2 MEXICO
12.5.2.1 Rising number of cosmetic procedures to boost adoption of biomaterials
12.5.3 ARGENTINA
12.5.3.1 Increased incidence of cardiovascular diseases and favorable government healthcare system to aid market growth
12.5.4 REST OF LATIN AMERICA
12.6 MIDDLE EAST
12.6.1 GCC COUNTRIES
12.6.1.1 Kingdom of Saudi Arabia
12.6.1.1.1 Increasing prevalence of cardiovascular diseases to drive market
12.6.1.2 UAE
12.6.1.2.1 Strategic partnerships and regulatory alignment to drive global biomaterials market growth
12.6.1.3 Rest of GCC countries
12.6.2 REST OF MIDDLE EAST
12.7 AFRICA
12.7.1 EXPANSION IN HEALTHCARE INDUSTRY AND SUPPORTIVE REGULATORY POLICIES TO AID MARKET GROWTH
13 COMPETITIVE LANDSCAPE
13.1 INTRODUCTION
13.2 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS
13.2.1 STRATEGIES ADOPTED BY KEY PLAYERS IN BIOMATERIALS MARKET
13.3 REVENUE ANALYSIS, 2023–2025
13.4 MARKET SHARE ANALYSIS, 2025
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
13.5.5 COMPETITIVE BENCHMARKING: KEY PLAYERS, 2025
13.5.5.1 Company footprint
13.5.5.2 Region footprint
13.5.5.3 Type footprint
13.5.5.4 Application footprint
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES
13.6.1 PROGRESSIVE COMPANIES
13.6.2 RESPONSIVE COMPANIES
13.6.3 DYNAMIC COMPANIES
13.6.4 STARTING BLOCKS
13.6.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES
13.6.5.1 List of key startups/SMEs
13.6.5.2 Competitive benchmarking of key startups/SMEs
13.7 COMPANY VALUATION & FINANCIAL METRICS
13.7.1 FINANCIAL METRICS
13.7.2 COMPANY VALUATION
13.8 BRAND/PRODUCT COMPARATIVE ANALYSIS
13.9 COMPETITIVE SCENARIO
13.9.1 PRODUCT LAUNCHES
13.9.2 DEALS
13.9.3 EXPANSIONS
14 COMPANY PROFILES
14.1 KEY PLAYERS
14.1.1 BASF SE
14.1.1.1 Business overview
14.1.1.2 Products/Services/Solutions offered
14.1.1.3 Recent developments
14.1.1.3.1 Deals
14.1.1.3.2 Other developments
14.1.1.4 MnM view
14.1.1.4.1 Right to win
14.1.1.4.2 Strategic choices
14.1.1.4.3 Weaknesses & competitive threats
14.1.2 COVESTRO AG
14.1.2.1 Business overview
14.1.2.2 Products/Services/Solutions offered
14.1.2.3 Recent developments
14.1.2.3.1 Product launches
14.1.2.3.2 Deals
14.1.2.3.3 Expansions
14.1.2.3.4 Other developments
14.1.2.4 MnM view
14.1.2.4.1 Right to win
14.1.2.4.2 Strategic choices
14.1.2.4.3 Weaknesses & competitive threats
14.1.3 CELANESE CORPORATION
14.1.3.1 Business overview
14.1.3.2 Products/Services/Solutions offered
14.1.3.3 Recent developments
14.1.3.3.1 Deals
14.1.3.4 MnM view
14.1.3.4.1 Right to win
14.1.3.4.2 Strategic choices
14.1.3.4.3 Weaknesses & competitive threats
14.1.4 CARPENTER TECHNOLOGY CORPORATION
14.1.4.1 Business overview
14.1.4.2 Products/Services/Solutions offered
14.1.4.2.1 Other developments
14.1.4.3 MnM view
14.1.4.3.1 Right to win
14.1.4.3.2 Strategic choices
14.1.4.3.3 Weaknesses & competitive threats
14.1.5 EVONIK INDUSTRIES AG
14.1.5.1 Business overview
14.1.5.2 Products/Services/Solutions offered
14.1.5.3 Recent developments
14.1.5.3.1 Product launches
14.1.5.3.2 Deals
14.1.5.4 MnM view
14.1.5.4.1 Right to win
14.1.5.4.2 Strategic choices
14.1.5.4.3 Weaknesses & competitive threats
14.1.6 DSM
14.1.6.1 Business overview
14.1.6.2 Products/Services/Solutions offered
14.1.6.3 Recent developments
14.1.6.3.1 Deals
14.1.6.3.2 Expansions
14.1.7 CORBION NV
14.1.7.1 Business overview
14.1.7.2 Products/Services/Solutions offered
14.1.7.3 Recent developments
14.1.7.3.1 Expansions
14.1.8 VICTREX PLC
14.1.8.1 Business overview
14.1.8.2 Products/Services/Solutions offered
14.1.8.3 Recent developments
14.1.8.3.1 Product launches
14.1.8.3.2 Expansions
14.1.9 MITSUBISHI CHEMICAL CORPORATION
14.1.9.1 Business overview
14.1.9.2 Products/Services/Solutions offered
14.1.10 COORSTEK INC.
14.1.10.1 Business overview
14.1.10.2 Products/Services/Solutions offered
14.1.11 BERKELEY ADVANCED BIOMATERIALS
14.1.11.1 Business overview
14.1.11.2 Products/Services/Solutions offered
14.1.12 CAM BIOCERAMICS B.V.
14.1.12.1 Business overview
14.1.12.2 Products/Services/Solutions offered
14.1.12.3 Recent developments
14.1.12.3.1 Deals
14.1.13 ZEUS COMPANY INC.
14.1.13.1 Business overview
14.1.13.2 Products/Services/Solutions offered
14.1.13.3 Recent developments
14.1.13.3.1 Product launches
14.1.13.3.2 Expansions
14.1.14 AMETEK INC.
14.1.14.1 Business overview
14.1.14.2 Products/Services/Solutions offered
14.1.14.3 Recent developments
14.1.14.3.1 Deals
14.1.14.3.2 Expansions
14.1.15 GELITA AG
14.1.15.1 Business overview
14.1.15.2 Products/Services/Solutions offered
14.1.15.3 Recent developments
14.1.15.3.1 Product launches
14.2 OTHER PLAYERS
14.2.1 COLLAGEN SOLUTIONS (US) LLC)
14.2.2 BIOCOMPOSITES
14.2.3 NOBLE BIOMATERIALS, INC.
14.2.4 REGENITY
14.2.5 KURARAY CO., LTD.
14.2.6 SOLESIS
14.2.7 INSTITUT STRAUMANN AG
14.2.8 FOSTER CORPORATION
14.2.9 CDI PRODUCTS
14.2.10 REVBIO, INC.
15 RESEARCH METHODOLOGY
15.1 RESEARCH DATA
15.1.1 SECONDARY DATA
15.1.1.1 Key objectives of secondary research
15.1.2 PRIMARY DATA
15.1.2.1 Breakdown of primaries
15.1.2.2 Key objectives of primary research
15.2 MARKET ESTIMATION METHODOLOGY
15.3 MARKET SIZE ESTIMATION
15.3.1 COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH)
15.3.2 MNM REPOSITORY ANALYSIS
15.3.3 PRIMARY INTERVIEWS
15.3.4 INSIGHTS OF PRIMARY EXPERTS
15.3.5 TOP-DOWN APPROACH
15.4 MARKET GROWTH RATE PROJECTIONS
15.5 DATA TRIANGULATION
15.6 STUDY ASSUMPTIONS
15.7 RESEARCH LIMITATIONS
15.8 RISK ANALYSIS
16 APPENDIX
16.1 DISCUSSION GUIDE
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3 CUSTOMIZATION OPTIONS
16.4 RELATED REPORTS
16.5 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 BIOMATERIALS MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 IMPACT ANALYSIS OF FACTORS IN BIOMATERIALS MARKET
TABLE 3 IMPACT OF PORTER’S FIVE FORCES ON BIOMATERIALS MARKET
TABLE 4 ROLE OF KEY COMPANIES (DEMAND/SUPPLY SIDES) IN BIOMATERIALS MARKET ECOSYSTEM
TABLE 5 INDICATIVE SELLING PRICE OF BIOMATERIALS, BY KEY PLAYER, 2025 (USD)
TABLE 6 INDICATIVE SELLING PRICE OF BIOMATERIALS, BY REGION, 2025 (USD)
TABLE 7 IMPORT DATA FOR HS CODE 7221 (STAINLESS STEEL), BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 8 EXPORT DATA FOR HS CODE 7221 (STAINLESS STEEL), BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 9 IMPORT VOLUME FOR HS CODE 7221 (STAINLESS STEEL), BY COUNTRY, 2021–2025 (TONS)
TABLE 10 EXPORT VOLUME FOR HS CODE 7221 (STAINLESS STEEL), BY COUNTRY, 2021–2025 (TONS)
TABLE 11 IMPORT DATA FOR HS CODE 284329 (SILVER), BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 12 EXPORT DATA FOR HS CODE 284329 (SILVER), BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 13 IMPORT VOLUME FOR HS CODE 284329 (SILVER), BY COUNTRY, 2021–2025 (TONS)
TABLE 14 EXPORT VOLUME FOR HS CODE 284329 (SILVER), BY COUNTRY, 2021–2025 (TONS)
TABLE 15 IMPORT DATA FOR HS CODE 281820 (ALUMINUM OXIDE), BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 16 EXPORT DATA FOR HS CODE 281820 (ALUMINUM OXIDE), BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 17 IMPORT VOLUME FOR HS CODE 281820 (ALUMINUM OXIDE), BY COUNTRY, 2021–2025 (TONS)
TABLE 18 EXPORT VOLUME FOR HS CODE 281820 (ALUMINUM OXIDE), BY COUNTRY, 2021–2025 (TONS)
TABLE 19 IMPORT DATA FOR HS CODE 3910 (SILICONE), BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 20 EXPORT DATA FOR HS CODE 3910 (SILICONE), BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 21 IMPORT VOLUME FOR HS CODE 3910 (SILICONE), BY COUNTRY, 2021–2025 (TONS)
TABLE 22 EXPORT VOLUME FOR HS CODE 3910, BY COUNTRY, 2021–2025 (TONS)
TABLE 23 KEY CONFERENCES & EVENTS IN BIOMATERIALS MARKET, JANUARY 2026–DECEMBER 2027
TABLE 24 CASE STUDY 1: SCALING MEDICAL-GRADE POLYMER SUPPLY THROUGH INTEGRATED VERBUND MANUFACTURING
TABLE 25 CASE STUDY 2: STRENGTHENING HIGH-PERFORMANCE POLYMER PLATFORMS FOR REGULATED BIOMATERIALS APPLICATIONS
TABLE 26 CASE STUDY 3: ADVANCING BIORESORBABLE AND BIOCOMPATIBLE MATERIALS FOR CLINICAL AND COMMERCIAL SCALE-UP
TABLE 27 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 28 INDICATIVE LIST OF PATENTS IN BIOMATERIALS MARKET, 2025
TABLE 29 CASE STUDIES OF AI IMPLEMENTATION IN BIOMATERIALS MARKET
TABLE 30 CLIENT’S READINESS TO ADOPT GENERATIVE AI IN BIOMATERIALS MARKET
TABLE 31 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 32 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 33 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 34 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 35 COUNTRY-WISE REGULATORY SCENARIO FOR BIOMATERIAL MANUFACTURERS
TABLE 36 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY TYPE (%)
TABLE 37 KEY BUYING CRITERIA, BY END USER
TABLE 38 IMPORTANT PROPERTIES OF BIOMATERIALS, BY APPLICATION
TABLE 39 BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 40 METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 41 METALLIC BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 42 STAINLESS STEEL BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 43 TITANIUM & TITANIUM ALLOY BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 44 COBALT-CHROME ALLOY BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 45 SILVER BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 46 GOLD BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 47 MAGNESIUM BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 48 OTHER METALLIC BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 49 APPLICATIONS OF SYNTHETIC POLYMERS
TABLE 50 POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 51 POLYMERIC BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 52 POLYMETHYLMETHACRYLATE (PMMA) BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 53 POLYETHYLENE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 54 POLYESTER BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 55 POLYVINYLCHLORIDE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 56 SILICONE RUBBER BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 57 NYLON BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 58 POLYETHERETHERKETONE (PEEK) BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 59 OTHER POLYMERIC BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 60 CERAMIC BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 61 CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 62 CALCIUM PHOSPHATE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 63 ZIRCONIA BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 64 ALUMINUM OXIDE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 65 CALCIUM SULFATE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 66 CARBON BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 67 GLASS BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 68 APPLICATIONS OF NATURAL BIOMATERIALS
TABLE 69 NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 70 NATURAL BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 71 HYALURONIC ACID BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 72 COLLAGEN BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 73 FIBRIN BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 74 CELLULOSE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 75 CHITIN BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 76 ALGINATES BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 77 GELATIN BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 78 CHITOSAN BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 79 SILK BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 80 OTHER NATURAL BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 81 BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 82 BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 83 BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 84 JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 85 JOINT REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 86 KNEE REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 87 HIP REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 88 SHOULDER REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 89 OTHER JOINT REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 90 BIORESORBABLE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 91 BIORESORBABLE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 92 SUTURE ANCHOR BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 93 INTERFERENCE SCREW BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 94 MENISCAL REPAIR TACK BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 95 MESH BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 96 BIOMATERIALS MARKET FOR SPINE SURGERIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 97 BIOMATERIALS MARKET FOR SPINE SURGERIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 98 SPINAL FUSION BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 99 MINIMALLY INVASIVE FUSION BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 100 BIOMATERIALS MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 101 MOTION PRESERVATION & DYNAMIC STABILIZATION BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 102 PEDICLE-BASED ROD SYSTEM BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 103 INTERSPINOUS SPACER BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 104 ARTIFICIAL DISC BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 105 BIOMATERIALS MARKET FOR FRACTURE FIXATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 106 FRACTURE FIXATION BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 107 BONE PLATE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 108 SCREW BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 109 PIN BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 110 ROD BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 111 WIRE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 112 ORTHOBIOLOGICS BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 113 BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 114 BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 115 CATHETER BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 116 STENT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 117 IMPLANTABLE CARDIAC DEFIBRILLATOR BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 118 PACEMAKER BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 119 SENSOR BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 120 BIOMATERIALS USED FOR DIFFERENT VALVE COMPONENTS
TABLE 121 HEART VALVE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 122 VASCULAR GRAFT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 123 GUIDEWIRE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 124 OTHER CARDIOVASCULAR BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 125 BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 126 BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 127 CONTACT LENSE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 128 INTRAOCULAR LENSE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 129 FUNCTIONAL REPLACEMENTS OF OCULAR TISSUE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 130 SYNTHETIC CORNEA BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 131 OTHER OPHTHALMOLOGY BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 132 BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 133 BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 134 DENTAL IMPLANT BIOMAERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 135 DENTAL BONE GRAFT & SUBSTITUTE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 136 DENTAL MEMBRANE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 137 TISSUE REGENERATION BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 138 BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 139 BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 140 SOFT TISSUE FILLERS BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 141 CRANIOFACIAL SURGERY BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 142 FACIAL WRINKLE TREATMENT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 143 BIOENGINEERED SKIN BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 144 PERIPHERAL NERVE REPAIR BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 145 ACELLULAR DERMAL MATRICE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 146 BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 147 BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 148 WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 149 WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 150 SUTURE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 151 STAPLE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 152 SURGICAL HEMOSTAT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 153 INTERNAL TISSUE SEALANT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 154 ADHESION BARRIER BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 155 HERNIA MESH BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 156 SKIN SUBSTITUTE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 157 BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 158 BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 159 SCAFFOLDS FOR BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 160 NANOMATERIALS FOR BIOSENSING BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 161 TAILORING OF INORGANIC NANOPARTICLE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 162 BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 163 BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS,BY REGION, 2024–2031 (USD MILLION)
TABLE 164 SHUNTING SYSTEM BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 165 CORTICAL NEURAL PROSTHETIC BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 166 HYDROGEL SCAFFOLD FOR CNS REPAIR BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 167 NEURAL STEM CELL ENCAPSULATION BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 168 BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 169 BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 170 URINARY CATHETER BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 171 URETHRAL STENT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 172 OTHER URINARY BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 173 BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 174 BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 175 DRUG DELIVERY SYSTEM BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 176 GASTROINTESTINAL APPLICATION BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 177 BARIATRIC SURGERY BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 178 BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 179 BIOMATERIALS MARKET FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2024–2031(USD MILLION)
TABLE 180 BIOMATERIALS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 181 BIOMATERIALS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 182 BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 183 NORTH AMERICA: BIOMATERIALS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 184 NORTH AMERICA: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 185 NORTH AMERICA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 186 NORTH AMERICA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 187 NORTH AMERICA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 188 NORTH AMERICA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 189 NORTH AMERICA: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 190 NORTH AMERICA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 191 NORTH AMERICA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 192 NORTH AMERICA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 193 NORTH AMERICA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 194 NORTH AMERICA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 195 NORTH AMERICA: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 196 NORTH AMERICA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 197 NORTH AMERICA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 198 NORTH AMERICA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 199 NORTH AMERICA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 200 NORTH AMERICA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 201 NORTH AMERICA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 202 NORTH AMERICA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 203 NORTH AMERICA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 204 NORTH AMERICA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 205 NORTH AMERICA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 206 NORTH AMERICA: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 207 US: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 208 US: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 209 US: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 210 US: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 211 US: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 212 US: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 213 US: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 214 US: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 215 US: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 216 US: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 217 US: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 218 US: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 219 US: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 220 US: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 221 US: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 222 US: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 223 US: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 224 US: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 225 US: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 226 US: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 227 US: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 228 US: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 229 US: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 230 CANADA: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 231 CANADA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 232 CANADA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 233 CANADA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 234 CANADA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 235 CANADA: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 236 CANADA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 237 CANADA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 238 CANADA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 239 CANADA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 240 CANADA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 241 CANADA: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 242 CANADA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 243 CANADA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 244 CANADA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 245 CANADA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 246 CANADA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 247 CANADA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 248 CANADA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 249 CANADA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 250 CANADA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 251 CANADA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 252 CANADA: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 253 EUROPE: BIOMATERIALS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 254 EUROPE: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 255 EUROPE: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 256 EUROPE: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 257 EUROPE: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 258 EUROPE: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 259 EUROPE: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 260 EUROPE: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 261 EUROPE: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 262 EUROPE: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 263 EUROPE: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 264 EUROPE: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 265 EUROPE: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 266 EUROPE: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 267 EUROPE: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 268 EUROPE: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 269 EUROPE: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 270 EUROPE: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 271 EUROPE: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 272 EUROPE: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 273 EUROPE: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 274 EUROPE: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 275 EUROPE: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 276 EUROPE: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 277 GERMANY: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 278 GERMANY: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 279 GERMANY: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 280 GERMANY: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 281 GERMANY: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 282 GERMANY: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 283 GERMANY: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 284 GERMANY: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 285 GERMANY: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 286 GERMANY: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 287 GERMANY: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 288 GERMANY: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 289 GERMANY: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 290 GERMANY: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 291 GERMANY: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 292 GERMANY: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 293 GERMANY: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 294 GERMANY: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 295 GERMANY: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 296 GERMANY: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 297 GERMANY: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 298 GERMANY: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 299 GERMANY: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 300 UK: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 301 UK: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 302 UK: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 303 UK: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 304 UK: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 305 UK: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 306 UK: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 307 UK: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 308 UK: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 309 UK: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 310 UK: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 311 UK: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 312 UK: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 313 UK: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 314 UK: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 315 UK: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 316 UK: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 317 UK: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 318 UK: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 319 UK: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 320 UK: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 321 UK: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 322 UK: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 1 BIOMATERIALS MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 IMPACT ANALYSIS OF FACTORS IN BIOMATERIALS MARKET
TABLE 3 IMPACT OF PORTER’S FIVE FORCES ON BIOMATERIALS MARKET
TABLE 4 ROLE OF KEY COMPANIES (DEMAND/SUPPLY SIDES) IN BIOMATERIALS MARKET ECOSYSTEM
TABLE 5 INDICATIVE SELLING PRICE OF BIOMATERIALS, BY KEY PLAYER, 2025 (USD)
TABLE 6 INDICATIVE SELLING PRICE OF BIOMATERIALS, BY REGION, 2025 (USD)
TABLE 7 IMPORT DATA FOR HS CODE 7221 (STAINLESS STEEL), BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 8 EXPORT DATA FOR HS CODE 7221 (STAINLESS STEEL), BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 9 IMPORT VOLUME FOR HS CODE 7221 (STAINLESS STEEL), BY COUNTRY, 2021–2025 (TONS)
TABLE 10 EXPORT VOLUME FOR HS CODE 7221 (STAINLESS STEEL), BY COUNTRY, 2021–2025 (TONS)
TABLE 11 IMPORT DATA FOR HS CODE 284329 (SILVER), BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 12 EXPORT DATA FOR HS CODE 284329 (SILVER), BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 13 IMPORT VOLUME FOR HS CODE 284329 (SILVER), BY COUNTRY, 2021–2025 (TONS)
TABLE 14 EXPORT VOLUME FOR HS CODE 284329 (SILVER), BY COUNTRY, 2021–2025 (TONS)
TABLE 15 IMPORT DATA FOR HS CODE 281820 (ALUMINUM OXIDE), BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 16 EXPORT DATA FOR HS CODE 281820 (ALUMINUM OXIDE), BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 17 IMPORT VOLUME FOR HS CODE 281820 (ALUMINUM OXIDE), BY COUNTRY, 2021–2025 (TONS)
TABLE 18 EXPORT VOLUME FOR HS CODE 281820 (ALUMINUM OXIDE), BY COUNTRY, 2021–2025 (TONS)
TABLE 19 IMPORT DATA FOR HS CODE 3910 (SILICONE), BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 20 EXPORT DATA FOR HS CODE 3910 (SILICONE), BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 21 IMPORT VOLUME FOR HS CODE 3910 (SILICONE), BY COUNTRY, 2021–2025 (TONS)
TABLE 22 EXPORT VOLUME FOR HS CODE 3910, BY COUNTRY, 2021–2025 (TONS)
TABLE 23 KEY CONFERENCES & EVENTS IN BIOMATERIALS MARKET, JANUARY 2026–DECEMBER 2027
TABLE 24 CASE STUDY 1: SCALING MEDICAL-GRADE POLYMER SUPPLY THROUGH INTEGRATED VERBUND MANUFACTURING
TABLE 25 CASE STUDY 2: STRENGTHENING HIGH-PERFORMANCE POLYMER PLATFORMS FOR REGULATED BIOMATERIALS APPLICATIONS
TABLE 26 CASE STUDY 3: ADVANCING BIORESORBABLE AND BIOCOMPATIBLE MATERIALS FOR CLINICAL AND COMMERCIAL SCALE-UP
TABLE 27 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 28 INDICATIVE LIST OF PATENTS IN BIOMATERIALS MARKET, 2025
TABLE 29 CASE STUDIES OF AI IMPLEMENTATION IN BIOMATERIALS MARKET
TABLE 30 CLIENT’S READINESS TO ADOPT GENERATIVE AI IN BIOMATERIALS MARKET
TABLE 31 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 32 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 33 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 34 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 35 COUNTRY-WISE REGULATORY SCENARIO FOR BIOMATERIAL MANUFACTURERS
TABLE 36 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY TYPE (%)
TABLE 37 KEY BUYING CRITERIA, BY END USER
TABLE 38 IMPORTANT PROPERTIES OF BIOMATERIALS, BY APPLICATION
TABLE 39 BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 40 METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 41 METALLIC BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 42 STAINLESS STEEL BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 43 TITANIUM & TITANIUM ALLOY BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 44 COBALT-CHROME ALLOY BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 45 SILVER BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 46 GOLD BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 47 MAGNESIUM BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 48 OTHER METALLIC BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 49 APPLICATIONS OF SYNTHETIC POLYMERS
TABLE 50 POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 51 POLYMERIC BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 52 POLYMETHYLMETHACRYLATE (PMMA) BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 53 POLYETHYLENE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 54 POLYESTER BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 55 POLYVINYLCHLORIDE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 56 SILICONE RUBBER BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 57 NYLON BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 58 POLYETHERETHERKETONE (PEEK) BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 59 OTHER POLYMERIC BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 60 CERAMIC BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 61 CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 62 CALCIUM PHOSPHATE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 63 ZIRCONIA BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 64 ALUMINUM OXIDE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 65 CALCIUM SULFATE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 66 CARBON BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 67 GLASS BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 68 APPLICATIONS OF NATURAL BIOMATERIALS
TABLE 69 NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 70 NATURAL BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 71 HYALURONIC ACID BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 72 COLLAGEN BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 73 FIBRIN BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 74 CELLULOSE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 75 CHITIN BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 76 ALGINATES BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 77 GELATIN BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 78 CHITOSAN BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 79 SILK BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 80 OTHER NATURAL BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 81 BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 82 BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 83 BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 84 JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 85 JOINT REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 86 KNEE REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 87 HIP REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 88 SHOULDER REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 89 OTHER JOINT REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 90 BIORESORBABLE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 91 BIORESORBABLE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 92 SUTURE ANCHOR BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 93 INTERFERENCE SCREW BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 94 MENISCAL REPAIR TACK BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 95 MESH BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 96 BIOMATERIALS MARKET FOR SPINE SURGERIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 97 BIOMATERIALS MARKET FOR SPINE SURGERIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 98 SPINAL FUSION BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 99 MINIMALLY INVASIVE FUSION BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 100 BIOMATERIALS MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 101 MOTION PRESERVATION & DYNAMIC STABILIZATION BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 102 PEDICLE-BASED ROD SYSTEM BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 103 INTERSPINOUS SPACER BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 104 ARTIFICIAL DISC BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 105 BIOMATERIALS MARKET FOR FRACTURE FIXATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 106 FRACTURE FIXATION BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 107 BONE PLATE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 108 SCREW BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 109 PIN BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 110 ROD BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 111 WIRE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 112 ORTHOBIOLOGICS BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 113 BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 114 BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 115 CATHETER BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 116 STENT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 117 IMPLANTABLE CARDIAC DEFIBRILLATOR BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 118 PACEMAKER BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 119 SENSOR BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 120 BIOMATERIALS USED FOR DIFFERENT VALVE COMPONENTS
TABLE 121 HEART VALVE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 122 VASCULAR GRAFT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 123 GUIDEWIRE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 124 OTHER CARDIOVASCULAR BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 125 BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 126 BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 127 CONTACT LENSE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 128 INTRAOCULAR LENSE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 129 FUNCTIONAL REPLACEMENTS OF OCULAR TISSUE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 130 SYNTHETIC CORNEA BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 131 OTHER OPHTHALMOLOGY BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 132 BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 133 BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 134 DENTAL IMPLANT BIOMAERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 135 DENTAL BONE GRAFT & SUBSTITUTE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 136 DENTAL MEMBRANE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 137 TISSUE REGENERATION BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 138 BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 139 BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 140 SOFT TISSUE FILLERS BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 141 CRANIOFACIAL SURGERY BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 142 FACIAL WRINKLE TREATMENT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 143 BIOENGINEERED SKIN BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 144 PERIPHERAL NERVE REPAIR BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 145 ACELLULAR DERMAL MATRICE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 146 BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 147 BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 148 WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 149 WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 150 SUTURE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 151 STAPLE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 152 SURGICAL HEMOSTAT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 153 INTERNAL TISSUE SEALANT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 154 ADHESION BARRIER BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 155 HERNIA MESH BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 156 SKIN SUBSTITUTE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 157 BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 158 BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 159 SCAFFOLDS FOR BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 160 NANOMATERIALS FOR BIOSENSING BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 161 TAILORING OF INORGANIC NANOPARTICLE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 162 BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 163 BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS,BY REGION, 2024–2031 (USD MILLION)
TABLE 164 SHUNTING SYSTEM BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 165 CORTICAL NEURAL PROSTHETIC BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 166 HYDROGEL SCAFFOLD FOR CNS REPAIR BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 167 NEURAL STEM CELL ENCAPSULATION BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 168 BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 169 BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 170 URINARY CATHETER BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 171 URETHRAL STENT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 172 OTHER URINARY BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 173 BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 174 BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 175 DRUG DELIVERY SYSTEM BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 176 GASTROINTESTINAL APPLICATION BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 177 BARIATRIC SURGERY BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 178 BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 179 BIOMATERIALS MARKET FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2024–2031(USD MILLION)
TABLE 180 BIOMATERIALS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 181 BIOMATERIALS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 182 BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 183 NORTH AMERICA: BIOMATERIALS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 184 NORTH AMERICA: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 185 NORTH AMERICA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 186 NORTH AMERICA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 187 NORTH AMERICA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 188 NORTH AMERICA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 189 NORTH AMERICA: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 190 NORTH AMERICA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 191 NORTH AMERICA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 192 NORTH AMERICA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 193 NORTH AMERICA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 194 NORTH AMERICA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 195 NORTH AMERICA: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 196 NORTH AMERICA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 197 NORTH AMERICA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 198 NORTH AMERICA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 199 NORTH AMERICA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 200 NORTH AMERICA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 201 NORTH AMERICA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 202 NORTH AMERICA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 203 NORTH AMERICA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 204 NORTH AMERICA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 205 NORTH AMERICA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 206 NORTH AMERICA: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 207 US: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 208 US: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 209 US: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 210 US: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 211 US: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 212 US: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 213 US: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 214 US: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 215 US: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 216 US: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 217 US: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 218 US: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 219 US: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 220 US: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 221 US: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 222 US: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 223 US: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 224 US: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 225 US: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 226 US: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 227 US: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 228 US: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 229 US: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 230 CANADA: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 231 CANADA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 232 CANADA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 233 CANADA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 234 CANADA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 235 CANADA: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 236 CANADA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 237 CANADA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 238 CANADA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 239 CANADA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 240 CANADA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 241 CANADA: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 242 CANADA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 243 CANADA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 244 CANADA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 245 CANADA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 246 CANADA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 247 CANADA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 248 CANADA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 249 CANADA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 250 CANADA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 251 CANADA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 252 CANADA: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 253 EUROPE: BIOMATERIALS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 254 EUROPE: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 255 EUROPE: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 256 EUROPE: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 257 EUROPE: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 258 EUROPE: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 259 EUROPE: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 260 EUROPE: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 261 EUROPE: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 262 EUROPE: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 263 EUROPE: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 264 EUROPE: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 265 EUROPE: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 266 EUROPE: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 267 EUROPE: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 268 EUROPE: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 269 EUROPE: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 270 EUROPE: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 271 EUROPE: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 272 EUROPE: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 273 EUROPE: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 274 EUROPE: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 275 EUROPE: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 276 EUROPE: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 277 GERMANY: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 278 GERMANY: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 279 GERMANY: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 280 GERMANY: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 281 GERMANY: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 282 GERMANY: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 283 GERMANY: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 284 GERMANY: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 285 GERMANY: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 286 GERMANY: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 287 GERMANY: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 288 GERMANY: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 289 GERMANY: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 290 GERMANY: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 291 GERMANY: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 292 GERMANY: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 293 GERMANY: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 294 GERMANY: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 295 GERMANY: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 296 GERMANY: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 297 GERMANY: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 298 GERMANY: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 299 GERMANY: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 300 UK: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 301 UK: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 302 UK: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 303 UK: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 304 UK: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 305 UK: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 306 UK: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 307 UK: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 308 UK: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 309 UK: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 310 UK: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 311 UK: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 312 UK: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 313 UK: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 314 UK: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 315 UK: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 316 UK: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 317 UK: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 318 UK: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 319 UK: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 320 UK: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 321 UK: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 322 UK: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
LIST OF FIGURES
FIGURE 1 BIOMATERIALS MARKET SEGMENTATION
FIGURE 2 BIOMATERIALS MARKET: REGIONAL SCOPE
FIGURE 3 BIOMATERIALS MARKET: YEARS CONSIDERED
FIGURE 4 BIOMATERIALS MARKET SCENARIO
FIGURE 5 GLOBAL BIOMATERIALS MARKET SIZE, 2024–2031 (USD MILLION)
FIGURE 6 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN BIOMATERIALS MARKET, 2023–2026
FIGURE 7 DISRUPTIONS INFLUENCING BIOMATERIALS MARKET GROWTH
FIGURE 8 HIGH-GROWTH SEGMENTS IN BIOMATERIALS MARKET, BY TYPE, APPLICATION, END USER, AND REGION (2026–2031)
FIGURE 9 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN BIOMATERIALS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
FIGURE 10 RISING ADVANCEMENTS IN SMART, BIOCOMPATIBLE, AND 3D PRINTED BIOMATERIALS TO DRIVE MARKET
FIGURE 11 US AND METALLIC BIOMATERIALS ACCOUNTED FOR LARGEST MARKET SHARE IN 2025
FIGURE 12 CHINA TO REGISTER HIGHEST GROWTH RATE DURING STUDY PERIOD
FIGURE 13 BIOMATERIALS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 14 BIOMATERIALS MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 15 BIOMATERIALS MARKET: VALUE CHAIN ANALYSIS
FIGURE 16 BIOMATERIALS MARKET ECOSYSTEM ANALYSIS
FIGURE 17 INDICATIVE SELLING PRICE OF BIOMATERIALS, BY KEY PLAYER, 2025 (USD)
FIGURE 18 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS IN BIOMATERIALS MARKET
FIGURE 19 FUNDING AND NUMBER OF DEALS IN BIOMATERIALS MARKET, 2025 (USD MILLION)
FIGURE 20 TOP APPLICANTS/OWNERS (COMPANIES) FOR BIOMATERIAL PATENTS, 2015–2025
FIGURE 21 IMPACT OF AI/GEN AI ON BIOMATERIALS MARKET
FIGURE 22 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY TYPE
FIGURE 23 KEY BUYING CRITERIA, BY END USER
FIGURE 24 NORTH AMERICA: BIOMATERIALS MARKET SNAPSHOT
FIGURE 25 ASIA PACIFIC: BIOMATERIALS MARKET SNAPSHOT
FIGURE 26 REVENUE ANALYSIS OF KEY PLAYERS IN BIOMATERIALS MARKET, 2023–2025 (USD MILLION)
FIGURE 27 BIOMATERIALS MARKET SHARE ANALYSIS OF KEY PLAYERS (2025)
FIGURE 28 BIOMATERIALS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 29 BIOMATERIALS MARKET: COMPANY FOOTPRINT
FIGURE 30 BIOMATERIALS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 31 EV/EBITDA OF KEY VENDORS
FIGURE 32 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 33 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY TYPE, IN BIOMATERIALS MARKET
FIGURE 34 BASF SE: COMPANY SNAPSHOT
FIGURE 35 COVESTRO AG: COMPANY SNAPSHOT
FIGURE 36 CELANESE CORPORATION: COMPANY SNAPSHOT
FIGURE 37 CARPENTER TECHNOLOGY CORPORATION: COMPANY SNAPSHOT
FIGURE 38 EVONIK INDUSTRIES AG: COMPANY SNAPSHOT
FIGURE 39 DSM: COMPANY SNAPSHOT
FIGURE 40 CORBION NV: COMPANY SNAPSHOT
FIGURE 41 VICTREX PLC: COMPANY SNAPSHOT
FIGURE 42 MITSUBISHI CHEMICAL CORPORATION: COMPANY SNAPSHOT
FIGURE 43 AMETEK.INC.: COMPANY SNAPSHOT
FIGURE 44 BIOMATERIALS MARKET: RESEARCH DESIGN
FIGURE 45 BIOMATERIALS MARKET: BREAKDOWN OF DEMAND- AND SUPPLY-SIDE PRIMARIES
FIGURE 46 BIOMATERIALS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2025
FIGURE 47 BIOMATERIALS MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS-BASED ESTIMATION, 2025
FIGURE 48 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF COVESTRO AG (2025)
FIGURE 49 BIOMATERIALS MARKET SIZE VALIDATION FROM PRIMARY SOURCES
FIGURE 50 BIOMATERIALS MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 51 BIOMATERIALS MARKET: CAGR PROJECTIONS
FIGURE 52 DATA TRIANGULATION METHODOLOGY IN BIOMATERIALS MARKET
FIGURE 1 BIOMATERIALS MARKET SEGMENTATION
FIGURE 2 BIOMATERIALS MARKET: REGIONAL SCOPE
FIGURE 3 BIOMATERIALS MARKET: YEARS CONSIDERED
FIGURE 4 BIOMATERIALS MARKET SCENARIO
FIGURE 5 GLOBAL BIOMATERIALS MARKET SIZE, 2024–2031 (USD MILLION)
FIGURE 6 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN BIOMATERIALS MARKET, 2023–2026
FIGURE 7 DISRUPTIONS INFLUENCING BIOMATERIALS MARKET GROWTH
FIGURE 8 HIGH-GROWTH SEGMENTS IN BIOMATERIALS MARKET, BY TYPE, APPLICATION, END USER, AND REGION (2026–2031)
FIGURE 9 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN BIOMATERIALS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
FIGURE 10 RISING ADVANCEMENTS IN SMART, BIOCOMPATIBLE, AND 3D PRINTED BIOMATERIALS TO DRIVE MARKET
FIGURE 11 US AND METALLIC BIOMATERIALS ACCOUNTED FOR LARGEST MARKET SHARE IN 2025
FIGURE 12 CHINA TO REGISTER HIGHEST GROWTH RATE DURING STUDY PERIOD
FIGURE 13 BIOMATERIALS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 14 BIOMATERIALS MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 15 BIOMATERIALS MARKET: VALUE CHAIN ANALYSIS
FIGURE 16 BIOMATERIALS MARKET ECOSYSTEM ANALYSIS
FIGURE 17 INDICATIVE SELLING PRICE OF BIOMATERIALS, BY KEY PLAYER, 2025 (USD)
FIGURE 18 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS IN BIOMATERIALS MARKET
FIGURE 19 FUNDING AND NUMBER OF DEALS IN BIOMATERIALS MARKET, 2025 (USD MILLION)
FIGURE 20 TOP APPLICANTS/OWNERS (COMPANIES) FOR BIOMATERIAL PATENTS, 2015–2025
FIGURE 21 IMPACT OF AI/GEN AI ON BIOMATERIALS MARKET
FIGURE 22 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY TYPE
FIGURE 23 KEY BUYING CRITERIA, BY END USER
FIGURE 24 NORTH AMERICA: BIOMATERIALS MARKET SNAPSHOT
FIGURE 25 ASIA PACIFIC: BIOMATERIALS MARKET SNAPSHOT
FIGURE 26 REVENUE ANALYSIS OF KEY PLAYERS IN BIOMATERIALS MARKET, 2023–2025 (USD MILLION)
FIGURE 27 BIOMATERIALS MARKET SHARE ANALYSIS OF KEY PLAYERS (2025)
FIGURE 28 BIOMATERIALS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 29 BIOMATERIALS MARKET: COMPANY FOOTPRINT
FIGURE 30 BIOMATERIALS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 31 EV/EBITDA OF KEY VENDORS
FIGURE 32 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 33 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY TYPE, IN BIOMATERIALS MARKET
FIGURE 34 BASF SE: COMPANY SNAPSHOT
FIGURE 35 COVESTRO AG: COMPANY SNAPSHOT
FIGURE 36 CELANESE CORPORATION: COMPANY SNAPSHOT
FIGURE 37 CARPENTER TECHNOLOGY CORPORATION: COMPANY SNAPSHOT
FIGURE 38 EVONIK INDUSTRIES AG: COMPANY SNAPSHOT
FIGURE 39 DSM: COMPANY SNAPSHOT
FIGURE 40 CORBION NV: COMPANY SNAPSHOT
FIGURE 41 VICTREX PLC: COMPANY SNAPSHOT
FIGURE 42 MITSUBISHI CHEMICAL CORPORATION: COMPANY SNAPSHOT
FIGURE 43 AMETEK.INC.: COMPANY SNAPSHOT
FIGURE 44 BIOMATERIALS MARKET: RESEARCH DESIGN
FIGURE 45 BIOMATERIALS MARKET: BREAKDOWN OF DEMAND- AND SUPPLY-SIDE PRIMARIES
FIGURE 46 BIOMATERIALS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2025
FIGURE 47 BIOMATERIALS MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS-BASED ESTIMATION, 2025
FIGURE 48 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF COVESTRO AG (2025)
FIGURE 49 BIOMATERIALS MARKET SIZE VALIDATION FROM PRIMARY SOURCES
FIGURE 50 BIOMATERIALS MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 51 BIOMATERIALS MARKET: CAGR PROJECTIONS
FIGURE 52 DATA TRIANGULATION METHODOLOGY IN BIOMATERIALS MARKET
